Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
European Journal of Medicinal Chemistry|October 15, 2017
Tying up tranylcypromine: Novel selective histone lysine specific demethylase 1 (LSD1) inhibitorsYue-Yang Ji, Sen-Dong Lin, Yu-Jie Wang, et al.RSC Advances|April 28, 2022
Design, synthesis and evaluation of novel indole-2-carboxamides for growth inhibition of <i>Mycobacterium tuberculosis</i> and paediatric brain tumour cellsShahinda S R Alsayed, Shichun Lun, Anders W Bailey, et al.Medchemcomm|September 9, 2020
Introducing nitrogen atoms to amidoalkylindoles: potent and selective cannabinoid type 2 receptor agonists with improved aqueous solubilityYue-Yang Ji, Zhi-Long Wang, Fang-Ning Pei, et al.Journal of Medicinal Chemistry|April 25, 2013
Preliminary structure-activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strainsOluseye K Onajole, Marco Pieroni, Suresh K Tipparaju, et al.ACS Chemical Neuroscience|April 3, 2014
The first CNS-active carborane: A novel P2X7 receptor antagonist with antidepressant activityShane M Wilkinson, Hendra Gunosewoyo, Melissa L Barron, et al.RSC Medicinal Chemistry|November 26, 2021
Synthesis and antitumour evaluation of indole-2-carboxamides against paediatric brain cancer cellsShahinda S R Alsayed, Amreena Suri, Anders W Bailey, et al.Journal of Medicinal Chemistry|January 13, 2018
Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosisWei Zhang, Shichun Lun, Shu-Huan Wang, et al.Chemmedchem|June 26, 2024
Synthesis and Antitumour Evaluation of Tricyclic Indole-2-Carboxamides against Paediatric Brain Cancer CellsAlexander John Hamilton, Samuel Lane, Eryn L Werry, et al.Antimicrobial Agents and Chemotherapy|August 21, 2019
Revisiting the β-Lactams for Tuberculosis Therapy with a Compound-Compound Synthetic Lethality ApproachShiqi Xiao, Haidan Guo, Warren S Weiner, et al.Journal of Medicinal Chemistry|June 17, 2016
Development of Novel Alkoxyisoxazoles as Sigma-1 Receptor Antagonists with Antinociceptive EfficacyHao Sun, Min Shi, Wei Zhang, et al.Pageof 5